Skip to main content
MNPR filings

Corporate insider profile

Raymond Anderson Filing Activity

Latest reported as Corporate insider of Monopar Therapeutics (MNPR).

Purchase filings
0
Reported companies
1
Net open-market value
-$351,189.20
Latest transaction
Aug 25, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 25, 2026Monopar Therapeutics (MNPR)Corporate insiderSale3,142$111.77$351,189